Introducing INSIGHT – Health Data Research Hub for Eye Health

INSIGHT is focused on eye disease and its application to wider health, including diabetes and dementia. It will use anonymised large-scale data and advanced analytics, including artificial intelligence, to develop new insights in disease detection, diagnosis, treatments and personalised healthcare. There is an increasing demand for ‘big data’ to enable innovation in health technologies and … Continue reading “Introducing INSIGHT – Health Data Research Hub for Eye Health”

Introducing PIONEER – Health Data Research Hub for Acute Care

By integrating information about how acutely unwell people access and use health services – such as from community health, the ambulance service and hospitals, PIONEER will allow innovative healthcare companies to develop, test and deliver advances in clinical care. Acute care is a catastrophic NHS burden, complex in scope but rich in innovation opportunities. Each … Continue reading “Introducing PIONEER – Health Data Research Hub for Acute Care”

PPI – a day in the life

What’s it really like to take part in research as a member of the public? In this blog, one of our patient and public involvement (PPI) volunteers recounts their experience at an advanced therapies focus group meeting The Midlands and Wales Advanced Therapy Treatment Centre (MW-ATTC) is interested in finding out what the public know … Continue reading “PPI – a day in the life”

MD-TEC stresses importance of usability for medical devices

In a recent BMJ article, Dr Tom Clutton-Brock, clinical director of the ERDF-funded Medical Devices Testing and Evaluation Centre (MD-TEC), commented on new European regulations and the effect they may have on the design of medical devices. Dr Clutton-Brock told a Clinical Human Factors Group (CHFG) meeting in London that new EU medical devices regulation … Continue reading “MD-TEC stresses importance of usability for medical devices”

Transforming the therapeutic scene: the story of diabetes drug discovery

Dr Abd Tahrani, Clinician Scientist at the University of Birmingham’s Institute of Metabolism and Systems Research, writes for BHP on the history of drug discovery in Type 2 diabetes; including modern non-pharmacological (lifestyle) interventions.      This week marks Diabetes UK’s annual Diabetes Week, with the aim of raising awareness about diabetes mellitus and tackling … Continue reading “Transforming the therapeutic scene: the story of diabetes drug discovery”